Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tiagabine in clinical practice.

P Genton1, R Guerrini, E Perucca

  • 1Centre Saint Paul, 13258 Marseille 09, France. piergen@aol.com

Epilepsia
|August 25, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic factors in epilepsy with eyelid myoclonia (Jeavons syndrome).

Revue neurologique·2023
Same author

Will MRI replace the EEG for the diagnosis of nonconvulsive status epilepticus, especially focal?

Revue neurologique·2021
Same author

Midazolam vs diazepam in prolonged seizures in children: A pharmacoeconomic approach.

Acta neurologica Scandinavica·2017
Same author

Joseph Roger. 1918-2012.

Neurophysiologie clinique = Clinical neurophysiology·2014
Same author

Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis.

Neuroscience·2012
Same author

Nifedipine versus fenoterol in the management of preterm labor: a randomized, multicenter clinical study.

Gynecologic and obstetric investigation·2012
Same journal

Factors associated with rapid pediatric acute seizure emergency treatment: Quality Improvement in Time to Treat Status Epilepticus baseline cohort.

Epilepsia·2026
Same journal

Outcome trajectories after pediatric epilepsy surgery vary by biopsychosocial phenotypes.

Epilepsia·2026
Same journal

Comparative risk of epilepsy with SGLT2 inhibitors versus incretin-based therapies in type 2 diabetes.

Epilepsia·2026
Same journal

Long-term mortality after status epilepticus: A 5-year analysis study.

Epilepsia·2026
Same journal

The Epilepsy-Cog study: Methods to establish a harmonized study of late onset epilepsy in a metacohort of six population-based cohorts in the United States.

Epilepsia·2026
Same journal

Systematic review and meta-analysis of lifestyle modification interventions and their impact on seizure reduction and quality of life.

Epilepsia·2026
See all related articles

Tiagabine (TGB), an antiepileptic drug, effectively reduces seizures in drug-resistant focal epilepsies by blocking GABA reuptake. While generally safe, careful titration is needed to manage side effects like dizziness and fatigue.

Area of Science:

  • Pharmacology
  • Neuroscience

Background:

  • Tiagabine (TGB) is a lipophilic nipecotic acid derivative.
  • It selectively inhibits gamma-aminobutyric acid (GABA) reuptake via the GAT-1 transporter.
  • TGB exhibits no other significant pharmacodynamic effects.

Purpose of the Study:

  • To review the efficacy and safety of tiagabine (TGB) as an antiepileptic drug.
  • To discuss its mechanism of action, pharmacokinetics, and clinical use.

Main Methods:

  • Review of placebo-controlled, double-blind, add-on studies.
  • Analysis of pharmacokinetic data and clinical practice observations.

Main Results:

  • TGB demonstrated efficacy and safety in add-on therapy for drug-resistant focal epilepsies.

Related Experiment Videos

  • Linear relationship between dose and blood levels; half-life is 7-9 hours, reduced by enzyme-inducing antiepileptic drugs (AEDs).
  • Common side effects include dizziness and fatigue, manageable with slow titration and administration during meals.

    • Conclusions:

    • Tiagabine is a safe and effective add-on treatment for focal epilepsies.
    • Further research is needed on its monotherapy use and efficacy in pediatric populations.
    • Potential benefit in temporal lobe epilepsies warrants further investigation.